pharma · Pulmonary Hypertension Associated with Interstitial Lung Disease · Pulmonary Arterial Hypertension
Insmed Incorporated
Insmed Limited
Insmed is a pharma organization headquartered in GB. Primary therapeutic focus areas include Pulmonary Hypertension Associated with Interstitial Lung Disease, Pulmonary Arterial Hypertension, Chronic Rhinosinusitis witho
Company details
- Status
- Public
- HQ
- Bridgewater Township, USA
- Employees
- 1,666
- Programs
- 7
- Drugs
- 18
- Patents
- 0
INS-416
Phase 3 · small molecule · "Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC)"
INS-416 for "Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC)" is a Phase 3 program (small_molecule) at Insmed Limited with 1 ClinicalTrials.gov record(s).
Internal code INS-416
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Insmed Limited
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- "Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC)"
- Status
- active
- Trials
- 1